Skip to content
Search

Latest Stories

Anuvab Pal on finding the funny and being part of a big UK tour

Easterneye.Biz Staff
By Easterneye.Biz StaffNov 07, 2019
Easterneye.Biz Staff
See Full Bio

by ASJAD NAZIR

Highly anticipated comedy tour The Indians Are Coming will be touching down at 16 venues across the UK and features top stand-up talent from around the world.

One of the comedians performing at every one of the Desi Central events is Anuvab Pal, who has flown in from India to join top British and American talent on stage. The acclaimed writer and stand-up comedian has made a name for himself on the live circuit with a variety of shows powered by hilarious jokes.

Eastern Eye caught up with Anuvab Pal to talk about The Indians Are Coming tour and all things comedy.

What first connected you to comedy?

I grew up in the 1980s India and people were taking things seriously that should not be taken. Someone had to notice and do something about it. So I started to find the funny in everyday life, and here I am, still doing the same.

How much are you looking forward to The Indians Are Coming tour?

I’ve been waiting for this tour the whole year and so am looking forward to connecting with British audiences. Desi Central has made a name in the UK for putting together stand-up comedy talent, so I am looking forward to sharing the bill with them and putting a smile on the face of audiences.

What can we expect from you?

You can expect lots of laughs from me and from all the others performing at the shows. From me, you can definitely expect jokes from 2019 modern India, where I live.

How do you feel being on a line-up with some amazing comedians?

As I said, Desi Central is known for putting together strong line-ups, so I do feel humbled and terrified.

How much of the comedy that you do is based on real life?

I always feel the best and most relatable comedy is honest. So all of it is based on my life.

Who is the funniest person you know in real life?

(Laughs) My father for sure! He says things without any filter.

Who is your comedy hero?

There have been so many comedy greats, but if I had to choose one it would be Eddie Izzard because he made his own rules. Oh, and my father!

Has being funny helped you in everyday life?

Not really! Nobody in my family listens to anything I’m saying, ever.

What inspires you?

Everyday India inspires me. It is impossible to not be inspired by that insanity.

Why should we come and watch The Indians Are Coming tour?

People say Indians are a serious hard-working people, only focused on doing well in academics and financial security. I think we’re the funniest people on the planet. Come find out for yourself!

Visit www.luventertainment.co.uk for tour dates

comedythe indians are comingstand-uptourdesi central

Related News

Azhar Mahmood
Cricket

Azhar Mahmood named interim red-ball head coach of Pakistan

India vs England: Gambhir faces growing pressure ahead of second Test
Cricket

India vs England: Gambhir faces growing pressure ahead of second Test

Beyonce car prop tilts
Entertainment

Beyoncé forced to stop Houston show as flying car stunt goes wrong in mid-air

More For You

Shefali Jariwala

Glutathione and anti ageing drugs under spotlight after Shefali Jariwala death

Instagram/shefalijariwala

Did anti-ageing pills, beauty supplements and glutathione trigger Shefali Jariwala’s death?

Quick highlights:

  • Shefali Jariwala died at 42 in Mumbai after reportedly collapsing post-fast; cause of death suspected to be cardiac arrest or blood pressure drop.
  • Police found anti-ageing pills, vitamin supplements, and glutathione injections at her residence.
  • Doctors stress the risks of unsupervised use of hormone-based and anti-ageing treatments.
  • Final post-mortem report expected in two days; no foul play suspected, case treated as accidental death.

The untimely death of actor-model Shefali Jariwala has sparked renewed concern over the unregulated use of anti-ageing treatments and self-medication. The 42-year-old, best known for her appearance in Kaanta Laga, was declared dead on arrival at a Mumbai hospital on Friday night. Initial investigations suggest she may have suffered a cardiac arrest following a steep drop in blood pressure, possibly linked to taking supplements on an empty stomach.

Keep ReadingShow less
Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Asian Media Group USA Inc